Florastor Liquid
Natural health product licensed in Canada
- Other names
- Florastor Go
- Licence holder
- Biocodex Canada Inc.
- NPN or DIN-HM
- 80094347
- Status
- Active licence
- Licence date
- 10 September 2019
- Revision date
- 13 November 2022
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Saccharomyces boulardii lyo Source : En entier | 5 Milliards d'UFC | Not calculated |
| Saccharomyces boulardii lyo Source : CNCM I-745 | 5 Milliards d'UFC | Not calculated |
| Saccharomyces boulardii lyo Source : En entier | 250 mg | Not calculated |
| Saccharomyces boulardii lyo Source : CNCM I-745 | 250 mg | Not calculated |
Non-medicinal ingredients
Lactose monohydraté, Saveur de fraise, Eau purifiée, Benzoate de sodium, Acide citrique, D-Fructose, Sorbate de potassium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes, adolescents et enfants | minimum: 3 months | minimum: 1 Portion(s) ; maximum: 2 Portion(s) | minimum: 1 day ; maximum: 2 days |
| Adultes, adolescents et enfants | minimum: 2 years | minimum: 1 Portion(s) ; maximum: 2 Portion(s) | minimum: 1 day ; maximum: 2 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of Probiotics. Helps support intestinal/gastrointestinal health. Could promote a favorable gut flora. Helps to reduce the risk of antibiotic-associated diarrhea. Helps prevent antibiotic associated diarrhea. Helps reduce the symptoms related to acute infectious diarrhea. Helps to reduce the risk of traveller's diarrhea. Helps to treat acute infectious diarrhea. An adjunct to physician-supervised antibiotic therapy in patients with Helicobacter pylori infections. Helps reduce recurrent Clostridium Difficile Associated Diarrhea (CDAD) when used as an adjunct to antibiotics.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80094347
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging